Free Access
Med Sci (Paris)
Volume 21, Number 3, Mars 2005
Page(s) 302 - 308
Section M/S revues
Published online 15 March 2005
  1. Reemtsma K, McCracken BH, Schlegel JU, et al. Heterotransplantation of the kidney : two clinical experiences. Science 1964; 143 : 700–2. [Google Scholar]
  2. Bailey LL, Nehlsen-Cannarella SL, Concepcion W, et al. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985; 254 : 3321–9. [Google Scholar]
  3. Groth CG. Deoxyspergualin in allogeneic kidney and xenogeneic islet transplantation : early clinical trials. Ann NY Acad Sci 1993; 685 : 193–5. [Google Scholar]
  4. Fink JS, Schumacher JM, Ellias SL, et al. Porcine xenografts in Parkinson’s disease and Huntington’s disease patients : preliminary results. Cell Transplant 2000; 9 : 273–8. [Google Scholar]
  5. Soin B, Smith KG, Zaidi A, et al. Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int 2001; 60 : 1592–7. [Google Scholar]
  6. Cozzi E, Bhatti F, Schmoeckel M, et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 70 : 15–21. [Google Scholar]
  7. Ramirez P, Chavez R, Majado M, et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 2000; 70 : 989–98. [Google Scholar]
  8. Starzl TE, Fung J, Tzakis A, et al. Baboon-to-human liver transplantation. Lancet 1993; 341 : 65–71. [Google Scholar]
  9. Daggett CW, Yeatman M, Lodge AJ, et al. Total respiratory support from swine lungs in primate recipients. J Thorac Cardiovasc Surg 1998; 115 : 19–27. [Google Scholar]
  10. Waterworth PD, Dunning J, Tolan M, et al. Life-supporting pig-to-baboon heart xenotransplantation. J Heart Lung Transplant 1998; 17 : 1201–7. [Google Scholar]
  11. Kuwaki K, Knosalla C, Dor FJ, et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am J Transplant 2004; 4 : 363–72. [Google Scholar]
  12. Kirchhof N, Shibata S, Wijkstrom M, et al. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 2004; 11 : 396–407. [Google Scholar]
  13. Kroshus TJ, Bolman RM, 3rd, Dalmasso AP. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation. Transplantation 1996; 62 : 5–12. [Google Scholar]
  14. Vanhove B, Bach FH. Human xenoreactive natural antibodies. Avidity and targets on porcine endothelial cells. Transplantation 1993; 56 : 1251–3. [Google Scholar]
  15. Platt JL, Vercellotti GM, Lindman BJ, et al. Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J Exp Med 1990; 171 : 1363–8. [Google Scholar]
  16. Xu Y, Lorf T, Sablinski T, et al. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Gal-alpha1-3Gal-beta1-4betaGlc-X immunoaffinity column. Transplantation 1998; 65 : 172–9. [Google Scholar]
  17. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55 : 857–66. [Google Scholar]
  18. Candinas D, Lesnikoski BA, Robson SC, et al. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Transplantation 1996; 62 : 336–42. [Google Scholar]
  19. Laumonier T, Mohacsi PJ, Matozan KM, et al. Endothelial cell protection by dextran sulfate : a novel strategy to prevent acute vascular rejection in xenotransplantation. Am J Transplant 2004; 4 : 181–7. [Google Scholar]
  20. Dalmasso AP, Vercellotti GM, Platt JL, et al. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 1991; 52 : 530–3. [Google Scholar]
  21. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1 : 964–6. [Google Scholar]
  22. Diamond LE, McCurry KR, Martin MJ, et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 1996; 61 : 1241–9. [Google Scholar]
  23. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995; 1 : 423–7. [Google Scholar]
  24. Loss M, Vangerow B, Schmidtko J, et al. Acute vascular rejection is associated with systemic complement activation in a pig-to-primate kidney xenograft model. Xenotransplantation 2000; 7 : 186–96. [Google Scholar]
  25. Dehoux JP, de la Parra B, Latinne D, et al. Characterization of baboon anti-porcine IgG antibodies during acute vascular rejection of porcine kidney xenograft. Xenotransplantation 2002; 9 : 338–49. [Google Scholar]
  26. Schaapherder AF, Daha MR, te Bulte MT, et al. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994; 57 : 1376–82. [Google Scholar]
  27. Ashton-Chess J, Roussel J, Bernard P, et al. The effect of immunoglobulin immunoadsorptions on delayed xenograft rejection of human CD55 transgenic pig kidneys in baboons. Xenotransplantation 2003; 10 : 552–61. [Google Scholar]
  28. Cooper DK, Koren E, Oriol R. Genetically engineered pigs. Lancet 1993; 342 : 682–3. [Google Scholar]
  29. Lai L, Kolber-Simonds D, Park KW, et al. Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295 : 1089–92. [Google Scholar]
  30. Houser SL, Kuwaki K, Knosalla C, et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004; 11 : 416–25. [Google Scholar]
  31. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors : initial experience. Nat Med 2005; 11 : 29–31. [Google Scholar]
  32. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11 : 32–4. [Google Scholar]
  33. Chen D, Riesbeck K, McVey JH, et al. Human thrombin and FXa mediate porcine endothelial cell activation. Modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins. Xenotransplantation 2001; 8 : 258–65. [Google Scholar]
  34. Riesbeck K, Chen D, Kemball-Cook G, et al. Expression of hirudin fusion proteins in mammalian cells : a strategy for prevention of intravascular thrombosis. Circulation 1998; 98 : 2744–52. [Google Scholar]
  35. Sebille F, Guillet M, Brouard S, et al. T-cell-mediated rejection of vascularized xenografts in the absence of induced anti-donor antibody response. Am J Transplant 2001; 1 : 21–8. [Google Scholar]
  36. Murray AG, Khodadoust MM, Pober JS, et al. Porcine aortic endothelial cells activate human T cells : direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1 : 57–63. [Google Scholar]
  37. Rollins SA, Kennedy SP, Chodera AJ, et al. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2. Transplantation 1994; 57 : 1709–16. [Google Scholar]
  38. Bartholomew AM, Powelson J, Sachs DH, et al. Tolerance in a concordant nonhuman primate model. Transplantation 1999; 68 : 1708–16. [Google Scholar]
  39. Kozlowski T, Shimizu A, Lambrigts D, et al. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation 1999; 67 : 18–30. [Google Scholar]
  40. Barth RN, Yamamoto S, LaMattina JC, et al. Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model. I. Evidence for pig-specific T-cell unresponsiveness. Transplantation 2003; 75 : 1615–24. [Google Scholar]
  41. Gollackner B, Mueller NJ, Houser S, et al. Porcine cytomegalovirus and coagulopathy in pig-to-primate xenotransplantation. Transplantation 2003; 75 : 1841–7. [Google Scholar]
  42. Martin U, Winkler ME, Id M, et al. Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation 2000; 7 : 138–42. [Google Scholar]
  43. Paradis K, Langford G, Long Z, et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 study group. Science 1999; 285 : 1236–41. [Google Scholar]
  44. Levy MF, Crippin J, Sutton S, et al. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers : clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation 2000; 69 : 272–80. [Google Scholar]
  45. Elliott RB, Escobar L, Garkavenko O, et al. No evidence of infection with porcine endogenous retrovirus in recipients of encapsulated porcine islet xenografts. Cell Transplant 2000; 9 : 895–901. [Google Scholar]
  46. Rother RP, Squinto SP. The alpha-galactosyl epitope : a sugar coating that makes viruses and cells unpalatable. Cell 1996; 86 : 185–8. [Google Scholar]
  47. Alexandre GP, Gianello P, Latinne D, et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation.In : Hardy MA, ed. Xenograft 25. New York : Excerpta Medica, 1989 : 259–66. [Google Scholar]
  48. Fischel RJ, Matas AJ, Platt JL, et al. Cardiac xenografting in the pig-to-Rhesus monkey model : manipulation of antiendothelial antibody prolongs survival. J Heart Lung Transplant 1992; 11 : 965–74. [Google Scholar]
  49. Ye Y, Neethling FA, Niekrasz M, et al. Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 1994; 58 : 330–7. [Google Scholar]
  50. Schmoeckel M, Bhatti FN, Zaidi A, et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 1998; 65 : 1570–7. [Google Scholar]
  51. Bhatti FN, Schmoeckel M, Zaidi A, et al. Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant Proc 1999; 31 : 958. [Google Scholar]
  52. McGregor CGA, Teotia SS, Schirmer JM, et al. Cardiac xenotransplantation : 4-1/2 month survival in the laboratory. Abstracts of the seventh congress of the International xenotransplantation association, Glasgow, 2003. Xenotransplantation 2003; 10 : 479–537. [Google Scholar]
  53. Menoret S, Plat M, Blancho G, et al. Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination. Transplantation 2004; 77 : 1468–71. [Google Scholar]
  54. Yamada K, Yazawa K, Kamono C, et al. An initial report of alpha-Gal deficient pig-to-baboon renal xenotransplantation : evidence for the benefit of cotransplanting vascularised donor thymic tissue. Abstracts of the seventh congress of the International xenotransplantation association, Glasgow, 2003. Xenotransplantation 2003; 10 : 479–537. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.